Status:

COMPLETED

Impact and Mechanism of Depression on Cardio-cerebral Vascular Events and Arteriovenous Fistula Dysfunction in MHD Patients

Lead Sponsor:

First Affiliated Hospital of Chongqing Medical University

Conditions:

Cardio-cerebral Vascular Events

Arteriovenous Fistula Dysfunction

Eligibility:

All Genders

18-90 years

Brief Summary

Depression is a common psychiatric disorder in patients on maintenance hemodialysis (MHD). It may contribute to poor prognosis in a number of ways, including its effect on platelet function. We aimed ...

Eligibility Criteria

Inclusion

  • Patients had undergone dialysis treatment for more than 3 months, and their medical status was stable at the time of enrollment, with an expected survival period of more than 1 year

Exclusion

  • (1) with communication disorders or mental illness other than depression; (2) a combination of cirrhosis, lymphoma, thrombocytopenic purpura, or other diseases that significantly affect platelet function; (3) complicated with malignant tumors, tuberculosis, severe heart failure, and unstable medical conditions; (4) inability or unwillingness to cooperate with researchers.

Key Trial Info

Start Date :

February 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 31 2023

Estimated Enrollment :

286 Patients enrolled

Trial Details

Trial ID

NCT06070805

Start Date

February 1 2022

End Date

May 31 2023

Last Update

October 6 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China, 400016